Skip to main content
Equibles
UTHR logo

UTHR · UNITED THERAPEUTICS Corp · Metrics

Track UTHR — free

Use UTHR with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

Claude ChatGPT Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$506.82 +8.85 (+1.78%)
S&P 400 member Russell 1000 member Rebalance outlook locked
Market Cap
$20.91B
Shares
42.89M

UTHR metrics

84 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$497.97
Market cap
$20.91B

Price action

20 metrics
Price change (1W)
-5.4%
Price change (30D)
-7.9%
Price change (3M)
-11.3%
Price change (6M)
+2.0%
Price change (YTD)
+0.1%
Price change (1Y)
+28.2%
Trailing year
Price change (5Y)
+131.3%
52-week high
$596.76
52-week low
$380.47
Change from 52-week high
-18.3%
Change from 52-week low
+28.2%
Annualized volatility
33.3%
Annualized volatility (3M)
22.2%
Beta
0.3
RSI (14D)
34.6
Price vs SMA 50
-7.2%
Price vs SMA 200
-6.8%
Avg volume (3M)
516,481
Relative volume
0.6
Average dollar volume
$273.73M

Company

3 metrics
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
42.89M

Valuation

12 metrics
P / E (TTM)
17.5
Trailing earnings · reciprocal yield 5.7%
PEG ratio
1.3
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
6.6×
reciprocal yield 15.1%
P / book
3.3
reciprocal yield 30.6%
FCF yield
5.2%
TTM · current market cap
Buyback yield
12.0%
P / FCF
19.1
reciprocal yield 5.2%
P / operating cash flow
12.4
reciprocal yield 8.1%
Earnings yield
6.3%

Historical valuation

8 metrics
P / E historical average (3Y)
15.1×
reciprocal yield 6.6%
P / E historical average (5Y)
15.1×
reciprocal yield 6.6%
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
12.0%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2026-08-05

Profitability

9 metrics
Gross margin
86.1%
Operating margin
44.4%
Trailing 12 months
Net margin
41.6%
Gross profit (TTM)
$2.72B
Operating profit (TTM)
$1.40B
Net income (TTM)
$1.31B
Trailing 12 months
Diluted EPS (TTM)
$27.91
FCF margin
34.6%
Effective tax rate
16.7%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$12.04

Growth

11 metrics
Revenue growth YoY
-1.9%
Year over year
Net income growth YoY
+7.6%
Revenue (TTM)
$3.15B
Trailing 12 months
EPS growth YoY
+13.4%
Shares change YoY
-5.2%
Year over year · fewer shares
Revenue CAGR (3Y)
+18.0%
Revenue CAGR (5Y)
+16.5%
EPS CAGR (3Y)
+22.9%
EPS CAGR (5Y)
+19.3%
FCF CAGR (3Y)
+16.2%
FCF CAGR (5Y)
+8.4%

Quality

14 metrics
Return on equity
20.5%
Return on assets
18.2%
Debt / equity
—
Current ratio
5.7
EBITDA (TTM)
$1.49B
Free cash flow (TTM)
$1.09B
Quick ratio
5.4
Interest coverage
116.8
Net debt / EBITDA
-1.8
Return on invested capital
—
Trailing 12 months
Net cash
$2.66B
Latest balance sheet
Cash & equivalents
$1.80B
Total assets
$7.22B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$1.69B
Capital expenditures (TTM)
$592.20M
R&D (TTM)
$551.50M
SG&A (TTM)
$764.00M
Stock compensation (TTM)
$155.40M
R&D / revenue
17.5%
Stock compensation / revenue
4.9%

Ownership (13F)

3 metrics
13F filers
878
13F filer change QoQ
+36
Institutional ownership
101.9%

Short interest

3 metrics
Short interest
4.9%
Latest settlement · 3.5 days to cover
Days to cover
3.5d
Short-squeeze score
46 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$348.94M
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1082554 CUSIP 91307C102 13F (30d) 477 filings 467 filers Visit website Investor relations